These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8262867)

  • 1. Efficacy of cefoperazone in combination with sulbactam in experimental Staphylococcus aureus endocarditis in rabbits.
    Chambers HF; Fournier MA
    J Antimicrob Chemother; 1993 Sep; 32(3):453-8. PubMed ID: 8262867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular correlation between in vitro and in vivo activity of beta-lactam and beta-lactamase inhibitor combinations against methicillin-resistant Staphylococcus aureus.
    Fasola EL; Fasching CE; Peterson LR
    J Lab Clin Med; 1995 Feb; 125(2):200-11. PubMed ID: 7844469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding affinity for penicillin-binding protein 2a correlates with in vivo activity of beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus.
    Chambers HF; Sachdeva M; Kennedy S
    J Infect Dis; 1990 Sep; 162(3):705-10. PubMed ID: 2387996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of resistance to cephalothin and gentamicin during combination therapy for methicillin-resistant Staphylococcus aureus endocarditis in rabbits.
    Chambers HF; Miller MH
    J Infect Dis; 1987 Mar; 155(3):581-5. PubMed ID: 3643249
    [No Abstract]   [Full Text] [Related]  

  • 5. Activity of cefpirome combined with beta-lactamase inhibitors and affinity for the penicillin-binding proteins of methicillin-resistant Staphylococcus aureus.
    Piddock LJ; Traynor EA; Griggs DJ
    Eur J Clin Microbiol Infect Dis; 1992 Apr; 11(4):364-71. PubMed ID: 1396760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo activities of a novel cephalosporin, BMS-247243, against methicillin-resistant and -susceptible staphylococci.
    Fung-Tomc JC; Clark J; Minassian B; Pucci M; Tsai YH; Gradelski E; Lamb L; Medina I; Huczko E; Kolek B; Chaniewski S; Ferraro C; Washo T; Bonner DP
    Antimicrob Agents Chemother; 2002 Apr; 46(4):971-6. PubMed ID: 11897577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ampicillin, sulbactam, and rifampin combination treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis in rabbits.
    Chambers HF; Kartalija M; Sande M
    J Infect Dis; 1995 Apr; 171(4):897-902. PubMed ID: 7706817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of penicillinase production for activity of penicillin alone or in combination with sulbactam in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Fantin B; Pierre J; Castéla-Papin N; Saint-Julien L; Drugeon H; Farinotti R; Carbon C
    Antimicrob Agents Chemother; 1996 May; 40(5):1219-24. PubMed ID: 8723470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of penicillinase on cefamandole treatment and prophylaxis of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Que YA; Entenza JM; Francioli P; Moreillon P
    J Infect Dis; 1998 Jan; 177(1):146-54. PubMed ID: 9419181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of ampicillin-sulbactam and oxacillin in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.
    Pefanis A; Thauvin-Eliopoulos C; Eliopoulos GM; Moellering RC
    Antimicrob Agents Chemother; 1993 Mar; 37(3):507-11. PubMed ID: 8460919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo antistaphylococcal activities of L-695,256, a carbapenem with high affinity for the penicillin-binding protein PBP 2a.
    Chambers HF
    Antimicrob Agents Chemother; 1995 Feb; 39(2):462-6. PubMed ID: 7726516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-lactam resistance mechanisms of methicillin-resistant Staphylococcus aureus.
    Franciolli M; Bille J; Glauser MP; Moreillon P
    J Infect Dis; 1991 Mar; 163(3):514-23. PubMed ID: 1995724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefoperazone: a review of its antimicrobial spectrum, beta-lactamase stability, enzyme inhibition, and other in vitro characteristics.
    Jones RN; Barry AL
    Rev Infect Dis; 1983; 5 Suppl 1():S108-26. PubMed ID: 6221381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis.
    Entenza JM; Hohl P; Heinze-Krauss I; Glauser MP; Moreillon P
    Antimicrob Agents Chemother; 2002 Jan; 46(1):171-7. PubMed ID: 11751129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excellent activity of FK037, a novel parenteral broad-spectrum cephalosporin, against methicillin-resistant staphylococci.
    Mine Y; Watanabe Y; Sakamoto H; Hatano K; Kuno K; Kamimura T; Tawara S; Matsumoto Y; Matsumoto F; Kuwahara S
    J Antibiot (Tokyo); 1993 Jan; 46(1):99-119. PubMed ID: 8436564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of beta-lactamase synthesis as a novel site of action for suppression of methicillin resistance in Staphylococcus aureus.
    Bruns O; Bruns W; Pulverer G
    Zentralbl Bakteriol; 1997 Feb; 285(3):413-30. PubMed ID: 9084115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further characterization of borderline methicillin-resistant Staphylococcus aureus and analysis of penicillin-binding proteins.
    Montanari MP; Tonin E; Biavasco F; Varaldo PE
    Antimicrob Agents Chemother; 1990 May; 34(5):911-3. PubMed ID: 2360829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amoxycillin-clavulanate versus methicillin or isoxazolyl penicillins for treatment of Staphylococcus aureus infections.
    Moreillon P
    J Antimicrob Chemother; 1995 Mar; 35(3):435-41. PubMed ID: 7782261
    [No Abstract]   [Full Text] [Related]  

  • 19. Terminology of Staphylococcus aureus strains showing decreased susceptibility to methicillin.
    Smith JM
    J Antimicrob Chemother; 1992 Feb; 29(2):219-21. PubMed ID: 1506337
    [No Abstract]   [Full Text] [Related]  

  • 20. New mechanism for methicillin resistance in Staphylococcus aureus: clinical isolates that lack the PBP 2a gene and contain normal penicillin-binding proteins with modified penicillin-binding capacity.
    Tomasz A; Drugeon HB; de Lencastre HM; Jabes D; McDougall L; Bille J
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1869-74. PubMed ID: 2610497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.